Personnel Information

写真a

ISHIKAWA JUNICHI


Job title

Assistant Professor

Graduating School 【 display / non-display

  • Chiba University, Graduate School of Medical and Pharmaceutical Sciences, 2023.03, Graduated

Campus Career 【 display / non-display

  • 2024.07
    -
    2024.09
    Tokyo Medical and Dental University, Medical Research Institute, Division of Biological Data Science, Department of Advanced Nanomedical Engineering, Assistant Professor
  • 2024.10
    -
    Now
    Institute of Science Tokyo, -, Institute of Integrated Research, Biological Data Science, Advanced Nanomedical Engineering, Assistant Professor

External Career 【 display / non-display

  • 2024.07
    -
    2024.09
    Tokyo Medical and Dental University, Medical Research Institute Advanced Nanomedical Engineering,
  • 2024.07
    -
    Now
    Kawasaki Institute of Industrial Promotion, Innovation Center of NanoMedicine (iCONM), Visiting Scientist
  • 2024.10
    -
    Now
    Institute of Science Tokyo, Institute for Integrated Research Medical Research Laboratory Advanced Nanomedical Engineering,

Research Areas 【 display / non-display

  • Connective tissue disease and allergy

  • Biomedical engineering

  • Immunology

 

Published Papers & Misc 【 display / non-display

  1. TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis 2023.05; 8 (10): ( PubMed, DOI )

  2. Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. 2023.01; 9 (1): ( PubMed, DOI )

  3. Hattori Koto, Tanaka Shigeru, Ishikawa Junichi, Yabe Yoko, Iwamoto Taro, Furuta Shunsuke, Ikeda Kei, Suzuki Kotaro, Nakajima Hiroshi. 全身性エリテマトーデス患者に対する非集中的維持療法中に生じた内臓播種性水痘帯状疱疹ウイルス感染症(Visceral disseminated varicella zoster virus infection during non-intensive maintenance therapy in a patient with systemic lupus erythematosus) Modern Rheumatology Case Reports. 2023.01; 7 (1): 57-59. ( ichushi )

  4. Visceral disseminated varicella zoster virus infection during non-intensive maintenance therapy in a patient with systemic lupus erythematosus. 2023.01; 7 (1): 57-59. ( PubMed, DOI )

  5. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab. 2019.12; 42 (4): 185-188. ( PubMed, DOI )

 

External class subject 【 display / non-display

  • IPE,Chiba University

  • Clinical clerkship elective learning courses in Chiba, Attending,School of Medicine, Chiba University